In support of the role of galectin-1 in tumor immunosuppression, in vivo blockage of galectin-1 expression in tumor cells of syngeneic mice promoted tumor rejection and stimulated tumor-specific T cell-mediated responses [122]. Here, LGALS1 is linked to neoplasm.